From: Risk factors for severe COVID-19 in the young—before and after ICU admission
< 50 years | 50–64 years | > 65 years | |
---|---|---|---|
Number (n) | 817 | 1797 | 2307 |
Age (mean (SD)) | 40.21 (7.85) | 57.77 (4.23) | 72.76 (5.27) |
Sex (women (%)) | 281 (34.4) | 496 (27.6) | 670 (29.0) |
Income category (%) | |||
1 | 455 (56.0) | 690 (38.5) | 1001 (43.5) |
2 | 251 (30.9) | 584 (32.6) | 691 (30.0) |
3 | 106 (13.1) | 520 (29.0) | 611 (26.5) |
Education (%) | |||
Primary | 178 (23.2) | 406 (23.0) | 801 (36.0) |
Secondary | 369 (48.2) | 852 (48.2) | 920 (41.3) |
Post-secondary | 219 (28.6) | 510 (28.8) | 507 (22.8) |
Region of birth (%) | |||
Africa | 64 (7.8) | 86 (4.8) | 63 (2.7) |
Asia | 222 (27.2) | 383 (21.3) | 256 (11.1) |
EU15, excl. Nordic | 5 (0.6) | 28 (1.6) | 65 (2.8) |
Europa, excl. EU15 and Nordic | 78 (9.5) | 160 (8.9) | 198 (8.6) |
North America | 2 (0.2) | 12 (0.7) | 5 (0.2) |
Nordic countries, excl. Sweden | 4 (0.5) | 73 (4.1) | 125 (5.4) |
Oceania | 0 (0.0) | 1 (0.1) | 0 (0.0) |
Soviet Union | 0 (0.0) | 1 (0.1) | 2 (0.1) |
Sweden | 425 (52.0) | 1 016 (56.5) | 1 548 (67.1) |
South America | 16 (2.0) | 34 (1.9) | 44 (1.9) |
Unknown | 1 (0.1) | 3 (0.2) | 1 (0) |
Pre-existing diagnoses (%) | |||
Hypertension | 84 (10.3) | 507 (28.2) | 1162 (50.4) |
Kidney disease | 21 (2.6) | 79 (4.4) | 142 (6.2) |
Rheumatoid arthritis | 11 (1.3) | 49 (2.7) | 72 (3.1) |
Systemic inflammatory disease | 11 (1.3) | 42 (2.3) | 83 (3.6) |
Inflammatory bowel disease | 14 (1.7) | 25 (1.4) | 42 (1.8) |
Venous thromboembolism | 21 (2.6) | 85 (4.7) | 164 (7.1) |
Obesity | 262 (32.1) | 515 (28.7) | 467 (20.2) |
Chronic obstructive pulmonary disease | 4 (0.5) | 47 (2.6) | 180 (7.8) |
Myocardial infarction | 6 (0.7) | 71 (4.0) | 198 (8.6) |
Heart failure | 9 (1.1) | 65 (3.6) | 222 (9.6) |
Atrial fibrillation | 8 (1.0) | 81 (4.5) | 337 (14.6) |
Type 1 diabetes | 19 (2.3) | 62 (3.5) | 121 (5.2) |
Asthma | 58 (7.1) | 149 (8.3) | 181 (7.8) |
Type 2 diabetes | 69 (8.4) | 287 (16.0) | 592 (25.7) |
Angina | 4 (0.5) | 65 (3.6) | 215 (9.3) |
Malignancy | 22 (2.7) | 97 (5.4) | 312 (13.5) |